Probity Advisors’s Celgene Corp CELG Stock Holding History

Probity Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,119	Closed	-$200K	–	173
2019 Q1	$200K	Buy	+2,119	New	+$185K	0.07%	164

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Probity Advisors's CELG Position: Q2 2019 in Review

Probity Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,119 shares — an estimated $200K sold.

Probity Advisors first reported a position in CELG in Q1 2019 and held it in 1 quarter. The position peaked at $200K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Probity Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Probity Advisors sold 2,119 Celgene Corp shares in Q2 2019, an estimated $200K.
Probity Advisors first reported a position in Celgene Corp in Q1 2019 and held it in 1 quarter.
Probity Advisors's Celgene Corp position peaked at $200K in Q1 2019.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Probity Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.